Novo Nordisk A/S's Novoeight Wins FDA Approval for Hemophilia A

Published: Oct 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Denmark's Novo Nordisk has received a licence application approval in the United States for its haemophilia drug Novoeight.

Help employers find you! Check out all the jobs and post your resume.

Back to news